Movano (NASDAQ:MOVE) Downgraded by Wall Street Zen to “Sell”

Wall Street Zen downgraded shares of Movano (NASDAQ:MOVE) from a hold rating to a sell rating in a report published on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Movano Trading Down 4.9%

Shares of NASDAQ MOVE opened at $19.90 on Friday. Movano has a twelve month low of $3.44 and a twelve month high of $25.69. The company has a market capitalization of $22.49 million, a price-to-earnings ratio of -1.88 and a beta of 0.80. The firm has a 50-day moving average of $14.72 and a two-hundred day moving average of $11.68.

Movano (NASDAQ:MOVE) last issued its quarterly earnings results on Monday, March 30th. The technology company reported ($5.88) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.60) by ($2.28). The business had revenue of $0.04 million during the quarter, compared to analyst estimates of $7.63 million. Movano had a negative net margin of 4,231.41% and a negative return on equity of 647.91%.

Hedge Funds Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new stake in Movano Inc. (NASDAQ:MOVE) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent reporting period. 16.64% of the stock is currently owned by institutional investors and hedge funds.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Movano completed its Corvex merger and secured continued Nasdaq listing, removing immediate delisting risk and giving the company a cleaner path forward. Movano Completes Corvex Merger and Retains Nasdaq Listing
• Neutral Sentiment: The merger may improve Movano’s strategic flexibility, but the market is likely waiting for more detail on execution, financing, and whether the combined company can improve operations and revenue growth.
• Negative Sentiment: Despite the Nasdaq retention, merger-related transitions often raise concerns about share dilution, integration risk, and whether the move is enough to address Movano’s weak financial performance and minimal revenue base.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.